Department of Health and Human Services and the nonprofit in charge of fundraising for the National Institutes of Health (NIH), the US government's primary medical research agency.

The Foundation for the NIH said that Avanir contributed "a modest amount" for the summit and was one of a number of financial backers -- none of which were involved in the development of the program. It noted that Avanir was contacted because it is a member of the highly-respected LEAD Coalition (Leaders Engaged on Alzheimer's Disease). LEAD declined a request from CNN for comment.

Avanir is also entering the world of academia. Currently, it is helping to launch an Alzheimer's training program at a New Jersey community college. The one-year "Alzheimer's Journey Coordination Certificate Program" is slated to start next fall atCamden County College and will train students to assist patients and their families with decisions ranging from housing and transportation to medical treatments. A representative from Avanir's parent company sits on the committee that is shaping the curriculum, led by the Rowan University/Rutgers-Camden Board of Governors.

New Jersey Congressman Donald Norcross, who was an earlier supporter of the training program, said he found the CNN's investigation into Nuedexta "deeply troubling." He said the program will be overseen by the joint board and will not include "any education around PBA or Nuedexta."

"It's never appropriate to put profits over people, especially when you're dealing with care for the most vulnerable among us," he said in a statement. "I support a full investigation into this matter and will certainly review the results."

This